MEET WITH OUR INVESTORS
ALMI Invest is the largest early-stage investment company in Sweden, owned by the Swedish State. Allan Asp represents ALMI Invest on PeptiSystems' board of directors.
PÄAB is a privately owned business angel investment fund that focuses on early-stage startups in technology and life sciences. Mats Johnson represents PÄAB on PeptiSystems' board of directors and is the former CEO of Bio-Works (a listed company).
Peter Ehrenheim
Peter Ehrenheim is an investor and chairman of several companies, including Bio-Works Technologies AB, Sophion Bioscience A/S, and Robustus Wear Components AB. He was previously General Manager at GE Healthcare’s Life Sciences business. Peter Ehrenheim's extensive expertise in life sciences and biotechnology sectors strengthens his strategic advisory roles in various companies.
Nolsterby Invest AB is a Stockholm-Uppsala-based family office founded in 2017. Nolsterby Invest AB is majority-owned by Erik Hedlund, a serial entrepreneur in medical technology.
Monesi Förvaltning AB
Monesi Förvaltning AB, founded in 2013, is an investment firm specializing in managing shares in subsidiaries and making strategic financial investments in Swedish and international companies. With total assets nearing 1 billion SEK and a net profit of 75 million SEK in 2022, it showcases significant financial strength. The firm benefits from the expertise of Henrik Didner, co-founder of Didner & Gerge Fonder, ensuring strategic oversight.
Rubicon Healthcare Partners (RHP) is a Nordic lifescience fund focused on growth-stage companies that enable the future of medicine. Rubicon partners with ambitious teams in the backbone industries of healthcare — from manufacturing technologies to advanced research tools — providing capital, competence, and a collaborative network to accelerate growth.